R13
Sign inGet started
🇫🇷

DAIICHI SANKYO FRANCE SAS (LABORATOIRES PHARMACEUTIQUES FORNET - SANKYO PHARMA FRANCE)

SIC46.46ZID382677144VATFR69382677144👥50employees

📍 8-10 RUE HENRI SAINTE-CLAIRE DEVILLE 92500 RUEIL-MALMAISON

Financial data

Sign in to unlock
Revenue
•••••
EBIT
•••••
EBITDA
•••••
Net result
•••••
Fiscal year
2025
Revenue, EBIT, net result and balance-sheet figures are as reported to the public register. EBITDA marked Estimated is derived from revenue × the sector-average margin (used where EBITDA is not publicly filed, e.g. France) and is not an audited figure.
Financial ratios — pre-computed profitability, liquidity, gearing and working-capital metrics from the latest filed accounts (INPI). Unlock to view.

Other companies in this sector

Same country and activity, ranked by how much data we hold. The list is free — open any company to see its own page.

PHOENIX OCPfinancials→COMPAGNIE D'EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE (CERP)financials→OCP REPARTITIONfinancials→ALLIANCE HEALTHCARE REPARTITION (AHR)financials→CONFRATERNELLE D'EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE RHIN RHONE MEDITERRANEE (CERP RHIN RHONE MEDI)financials→MSD FRANCEfinancials→

Direction

3
Sign in to unlock
  • •••••••••••
    •••••
  • •••••••••••
    •••••
  • •••••••••••
    •••••
2 board members · 1 corporate officer · unlocks alongside financials

ESG

Cross-referenced against public registries. Updated daily.

Index Égalité H/F
98/100
FY 2025 · 5 years on record
Conventions collectives

Establishments

1
SIRETAddressNAFStatus
••• ••• ••• •••••siège•• rue ••••••, ••••• Paris••.••Zactive

Recent events (BODACC)

96 more behind unlock
DateTypeLabelTribunal
2025-••-••MODIFICATION•••••••••••• ••••••Tribunal de •••••••
2025-••-••DPC•••••••••••• ••••••Tribunal de •••••••
2025-••-••MODIFICATION•••••••••••• ••••••Tribunal de •••••••

Data sourced from official commercial registries. Last updated when this company filed its accounts.